Jane Ann Davis, EVP of $CARE, sold 2,500 shares on June 5, 2025, for approximately $40,986, representing about 17.5% of their holdings in that class of stock; following the sale, Davis holds 11,800 shares. Over the last quarter, institutional investors showed mixed sentiment, with 52 increasing and 49 decreasing their positions; notable reductions came from ALLIANCEBERNSTEIN L.P. and FOURTHSTONE LLC, while MALTESE CAPITAL MANAGEMENT LLC significantly increased its stake.
Jane Ann Davis, EVP of $CARE, executed a notable sale of 2,500 company shares on June 5, 2025, for an estimated $40,986, reducing her holdings in this stock class by approximately 17.5% to 11,800 shares. This transaction is one of two insider trades in $CARE stock over the past six months, the other being a purchase of 200 shares by Catharine L. Midkiff. Institutional activity in $CARE during Q1 2025 presented a mixed picture, with 52 firms increasing their positions and 49 decreasing them. However, several significant institutions markedly reduced their stakes: AllianceBernstein L.P. cut its holdings by 91.8% (199,712 shares), Fourthstone LLC by 19.4% (107,080 shares), and UBS Group AG by 72.9% (98,774 shares). Other substantial reductions were seen from Goldman Sachs Group Inc. (-24.0%) and Arrowstreet Capital, Limited Partnership (-60.2%). In contrast, Maltese Capital Management LLC increased its portfolio by 43.5% (87,456 shares). The EVP's significant share sale, combined with the substantial net selling by prominent institutional investors, contributes to the moderately negative sentiment score of -0.6 observed for $CARE.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
moderately negative
Sentiment Score
-0.50
Ticker Sentiment
